Home > Insider Trading > Filing (0001209191-22-057656)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1420800	Enovis Corp	ENOV	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1205249	A Daniel Pryor	2711 Centerville Road Suite 400 Wilmington DE 19808	Evp, Strategy & Business Dev.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Acquisiton	2022-11-15	67,421	$45.06	143,152	No	4	M	Direct
Common Stock, Par Value $0.001	Disposition	2022-11-15	67,421	$54.58	75,731	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $.001	Employee Stock Option (right to buy)	Disposition	2022-11-15	67,421	$0.00	67,421	$45.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2023-11-16	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	932	Indirect	By 401k plan
Common Stock, Par Value $0.001	333	Indirect	By trust for daughter
Common Stock, Par Value $0.001	333	Indirect	By trust for daughter
Common Stock, Par Value $0.001	333	Indirect	By trust for son

Footnotes

Holdings reflect the adjustments that occurred as of April 4, 2022 in connection with the spin-off of ESAB Corporation by the Issuer. In connection with the spin-off, each outstanding restricted stock unit was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded down to the nearest whole unit. In addition, holdings have been updated to reflect the impact of the one-for-three reverse stock split effected by the Issuer on April 4, 2022.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.47 to $55.01, inclusive. The reporting person undertakes to provide to Enovis Corporation, any security holder of Enovis Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests in equal installments on the first, second and third anniversaries of the grant date, which was 11/15/2015